182 related articles for article (PubMed ID: 8358231)
1. Sialyltransferase activity in FR3T3 cells transformed with ras oncogene: decreased CMP-Neu5Ac:Gal beta 1-3GalNAc alpha-2,3-sialyltransferase.
Delannoy P; Pelczar H; Vandamme V; Verbert A
Glycoconj J; 1993 Feb; 10(1):91-8. PubMed ID: 8358231
[TBL] [Abstract][Full Text] [Related]
2. The c-Ha-ras oncogene induces increased expression of beta-galactoside alpha-2, 6-sialyltransferase in rat fibroblast (FR3T3) cells.
Le Marer N; Laudet V; Svensson EC; Cazlaris H; Van Hille B; Lagrou C; Stehelin D; Montreuil J; Verbert A; Delannoy P
Glycobiology; 1992 Feb; 2(1):49-56. PubMed ID: 1550989
[TBL] [Abstract][Full Text] [Related]
3. Regulation of alpha 2,3-sialyltransferase expression correlates with conversion of peanut agglutinin (PNA)+ to PNA- phenotype in developing thymocytes.
Gillespie W; Paulson JC; Kelm S; Pang M; Baum LG
J Biol Chem; 1993 Feb; 268(6):3801-4. PubMed ID: 8440675
[TBL] [Abstract][Full Text] [Related]
4. Comparison of sialyl- and alpha-1,3-galactosyltransferase activity in NIH3T3 cells transformed with ras oncogene: increased beta-galactoside alpha-2,6-sialyltransferase.
Vandamme V; Cazlaris H; Le Marer N; Laudet V; Lagrou C; Verbert A; Delannoy P
Biochimie; 1992 Jan; 74(1):89-99. PubMed ID: 1576213
[TBL] [Abstract][Full Text] [Related]
5. Evidence for an O-glycan sialylation system in brain. Characterization of a beta-galactoside alpha 2,3-sialyltransferase from rat brain regulating the expression of an alpha-N-acetylgalactosaminide alpha 2,6-sialyltransferase activity.
Baubichon-Cortay H; Broquet P; George P; Louisot P
Eur J Biochem; 1989 Jun; 182(2):257-65. PubMed ID: 2472271
[TBL] [Abstract][Full Text] [Related]
6. Donor substrate specificities of Gal beta 1,4GlcNAc alpha 2,6-sialyltransferase and Gal beta 1,3GalNAc alpha 2,3-sialyltransferase: comparison of N-acetyl and N-glycolylneuraminic acids.
Hamamoto T; Kurosawa N; Lee YC; Tsuji S
Biochim Biophys Acta; 1995 May; 1244(1):223-8. PubMed ID: 7766662
[TBL] [Abstract][Full Text] [Related]
7. High alpha-2,6-sialylation of N-acetyllactosamine sequences in ras-transformed rat fibroblasts correlates with high invasive potential.
Le Marer N; Stéhelin D
Glycobiology; 1995 Mar; 5(2):219-26. PubMed ID: 7780196
[TBL] [Abstract][Full Text] [Related]
8. Processing O-glycan core 1, Gal beta 1-3GalNAc alpha-R. Specificities of core 2, UDP-GlcNAc: Gal beta 1-3 GalNAc-R(GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase and CMP-sialic acid: Gal beta 1-3GalNAc-R alpha 3-sialyltransferase.
Kuhns W; Rutz V; Paulsen H; Matta KL; Baker MA; Barner M; Granovsky M; Brockhausen I
Glycoconj J; 1993 Oct; 10(5):381-94. PubMed ID: 8298305
[TBL] [Abstract][Full Text] [Related]
9. Determination of the specificities of rat liver Gal(beta 1-4)GlcNAc alpha 2,6-sialyltransferase and Gal(beta 1-3/4)GlcNAc alpha 2,3-sialyltransferase using synthetic modified acceptors.
Wlasichuk KB; Kashem MA; Nikrad PV; Bird P; Jiang C; Venot AP
J Biol Chem; 1993 Jul; 268(19):13971-7. PubMed ID: 8314763
[TBL] [Abstract][Full Text] [Related]
10. Study of O-glycan sialylation in C6 cultured glioma cells: evidence for post-translational regulation of a beta-galactoside alpha 2,3 sialyltransferase activity by N-glycosylation.
Broquet P; George P; Geoffroy J; Reboul P; Louisot P
Biochem Biophys Res Commun; 1991 Aug; 178(3):1437-43. PubMed ID: 1872858
[TBL] [Abstract][Full Text] [Related]
11. Different reactivity of two brain sialyltransferases towards sulfhydryl reagents. Evidence for a thiol group involved in the nucleotide-sugar binding site of the NeuAc alpha 2-3Gal beta 1-3GalNAc alpha(2-6)sialyltransferase.
Baubichon-Cortay H; Broquet P; George P; Louisot P
Glycoconj J; 1989; 6(1):115-27. PubMed ID: 2485232
[TBL] [Abstract][Full Text] [Related]
12. Alpha-2,3 sialylation differentiate the limbal and corneal epithelial cell phenotypes.
Wolosin JM; Wang Y
Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2277-86. PubMed ID: 7558722
[TBL] [Abstract][Full Text] [Related]
13. Sialyltransferases of developing rat brain.
Dall'Olio F
Glycoconj J; 1990; 7(4):301-10. PubMed ID: 1726633
[TBL] [Abstract][Full Text] [Related]
14. Purification and enzymatic characterization of CMP-sialic acid: beta-galactosyl1----3-N-acetylgalactosaminide alpha 2----3-sialyltransferase from human placenta.
Joziasse DH; Bergh ML; ter Hart HG; Koppen PL; Hooghwinkel GJ; Van den Eijnden DH
J Biol Chem; 1985 Apr; 260(8):4941-51. PubMed ID: 3988739
[TBL] [Abstract][Full Text] [Related]
15. Ras oncogene induces beta-galactoside alpha2,6-sialyltransferase (ST6Gal I) via a RalGEF-mediated signal to its housekeeping promoter.
Dalziel M; Dall'Olio F; Mungul A; Piller V; Piller F
Eur J Biochem; 2004 Sep; 271(18):3623-34. PubMed ID: 15355339
[TBL] [Abstract][Full Text] [Related]
16. Study of O-sialylation of glycoproteins in C6 glioma cells treated with retinoic acid.
Reboul P; George P; Miquel D; Louisot P; Broquet P
Glycoconj J; 1996 Feb; 13(1):69-79. PubMed ID: 8785491
[TBL] [Abstract][Full Text] [Related]
17. Characterization of terminal sialic acid linkages on human thymocytes. Correlation between lectin-binding phenotype and sialyltransferase expression.
Baum LG; Derbin K; Perillo NL; Wu T; Pang M; Uittenbogaart C
J Biol Chem; 1996 May; 271(18):10793-9. PubMed ID: 8631891
[TBL] [Abstract][Full Text] [Related]
18. alpha 2,3-Sialylation of terminal GalNAc beta 1-3Gal determinants by ST3Gal II reveals the multifunctionality of the enzyme. The resulting Neu5Ac alpha 2-3GalNAc linkage is resistant to sialidases from Newcastle disease virus and Streptococcus pneumoniae.
Toivonen S; Aitio O; Renkonen O
J Biol Chem; 2001 Oct; 276(40):37141-8. PubMed ID: 11479313
[TBL] [Abstract][Full Text] [Related]
19. Enzymatic synthesis of unique sialyloligosaccharides using marine bacterial alpha-(2-->3)- and alpha-(2-->6)-sialyltransferases.
Mine T; Miyazaki T; Kajiwara H; Naito K; Ajisaka K; Yamamoto T
Carbohydr Res; 2010 Jul; 345(10):1417-21. PubMed ID: 20413108
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas.
Schneider F; Kemmner W; Haensch W; Franke G; Gretschel S; Karsten U; Schlag PM
Cancer Res; 2001 Jun; 61(11):4605-11. PubMed ID: 11389097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
